First Affiliated Hospital Xi'an Jiaotong University
Phase
Observational
Started
2023-10-26
Last updated
2024-07-12
Condition(s) studied
Cardiac Tumor
Study summary
This study aims to retrospectively and prospectively collect clinical and biological specimen data from patients with cardiac tumors who meet the inclusion and exclusion criteria. Various techniques, including general molecular biology analysis and multi-omics analysis, will be used to construct a prognostic model for cardiac tumors.
Eligibility
Sex
ALL
Min age
3 Years
Max age
80 Years
Healthy volunteers
No
Inclusion Criteria:
* Patients who are regularly visited and followed up in the corresponding cardiovascular center.
* All patients must meet at least one of the following diagnostic criteria for cardiac neoplasms: 1. Cardiac myxoma group; 2. Cardiac fibroma group; 3. Cardiac lipoma group; 4. Cardiac hemangioma group; 5. Cardiac undifferentiated sarcoma; 6. Cardiac angiosarcoma group; 7. Cardiac rhabdomyosarcoma group; 8. Cardiac lymphoma group; 9. Cardiac metastasis group; 10. Other cardiac tumors group.
Exclusion Criteria:
* Age \<3 years or \>80 years old.
* Pregnant and lactating women.
* The patient declined to provide informed consent to participate in the study.
* None of the above was met, but the patient was temporarily unable to sign the informed consent form due to coma and other reasons, and no legal representative signed it instead. Depending on the patient's condition, the patient may not be able to regain consciousness and sign the informed consent form.
Primary outcome measure(s)
Change in the incidence of MACCE — 1, 3, 6, 12, 24, 36, 48, and 60 months after enrollment. MACCE (major adverse cardiac and cerebrovascular events) including all-cause death, myocardial infarction, coronary revascularization surgery and stroke. The MACCE will be assessed from the medical records.
Trial sites (1)
Facility
City
Region
Status
First Affiliated Hospital of Xi'an Jiantong University
Xi'an
Shaanxi
Recruiting
More First Affiliated Hospital Xi'an Jiaotong University trials in China
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.